Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy

被引:57
作者
Shoubridge, EA [1 ]
Johns, T [1 ]
Karpati, G [1 ]
机构
[1] MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ H3A 1B1,CANADA
基金
英国医学研究理事会;
关键词
D O I
10.1093/hmg/6.13.2239
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Replicative segregation of mitochondrial DNA (mtDNA) can produce large differences in the proportions of wild-type and mutant mtDNAs in different cell types of patients with mitochondrial encephalomyopathy. This is particularly striking in the skeletal muscle of patients with Kearns-Sayre syndrome (KSS), a sporadic disease associated with large-scale mtDNA deletions, and in sporadic patients with TRNA point mutations, Although the skeletal muscle fibres of these patients invariably contain a large proportion of mutant mtDNAs, mutant mtDNAs are rare or undetectable in satellite cells cultured from the same muscle biopsy specimens, Since satellite cells are responsible for muscle fibre regeneration, restoration of the wild-type mtDNA genotype might be achieved in these patients by encouraging muscle regeneration. To test this concept, we re-biopsied a patient with a KSS phenotype and a mtDNA point mutation in the tRNA(leu(CUN)) gene and analysed muscle fibres regenerating at the site of the original muscle biopsy, Regenerating fibres were identified by morphological criteria and by expression of neural cell adhesion molecule (NCAM), All such fibers were positive for cytochrome c oxidase (COX) activity by cytochemistry and essentially homoplasmic for wild-type mtDNA, while the majority of non-regenerating fibres were COX-negative and contained predominantly mutant mtDNAs, These results demonstrate that it may be possible to improve muscle function in similar patients by methods that promote satellite cell incorporation into existing myofibres.
引用
收藏
页码:2239 / 2242
页数:4
相关论文
共 29 条
  • [1] Baldwin TJ, 1996, J CELL BIOCHEM, V61, P502, DOI 10.1002/(SICI)1097-4644(19960616)61:4<502::AID-JCB3>3.0.CO
  • [2] 2-S
  • [3] BOULET L, 1992, AM J HUM GENET, V51, P1187
  • [4] MELAS MUTATION IN MTDNA BINDING-SITE FOR TRANSCRIPTION TERMINATION FACTOR CAUSES DEFECTS IN PROTEIN-SYNTHESIS AND IN RESPIRATION BUT NO CHANGE IN LEVELS OF UPSTREAM AND DOWNSTREAM MATURE TRANSCRIPTS
    CHOMYN, A
    MARTINUZZI, A
    YONEDA, M
    DAGA, A
    HURKO, O
    JOHNS, D
    LAI, ST
    NONAKA, I
    ANGELINI, C
    ATTARDI, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4221 - 4225
  • [5] Reversal of a mitochondrial DNA defect in human skeletal muscle
    Clark, KM
    Bindoff, LA
    Lightowlers, RN
    Andrew, RM
    Griffiths, PG
    Johnson, MA
    Brierley, EJ
    Turnbull, DM
    [J]. NATURE GENETICS, 1997, 16 (03) : 222 - 224
  • [6] A novel heteroplasmic tRNA(leu(CUN)) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy
    Fu, K
    Hartlen, R
    Johns, T
    Genge, A
    Karpati, G
    Shoubridge, EA
    [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (11) : 1835 - 1840
  • [7] Mitochondrial genetics and human disease
    Grossman, LI
    Shoubridge, EA
    [J]. BIOESSAYS, 1996, 18 (12) : 983 - 991
  • [8] HEUSS D, 1995, CLIN NEUROPATHOL, V14, P331
  • [9] DELETIONS OF MUSCLE MITOCHONDRIAL-DNA IN PATIENTS WITH MITOCHONDRIAL MYOPATHIES
    HOLT, IJ
    HARDING, AE
    MORGANHUGHES, JA
    [J]. NATURE, 1988, 331 (6158) : 717 - 719
  • [10] GENE-TRANSFER INTO SKELETAL-MUSCLES BY ISOGENIC MYOBLASTS
    HUARD, J
    ACSADI, G
    JANI, A
    MASSIE, B
    KARPATI, G
    [J]. HUMAN GENE THERAPY, 1994, 5 (08) : 949 - 958